$XNCR 4/A SEC Filings

Filed On	Filing
22 Jun 2023	Form 4/A: Ranieri Richard J, Director Received 5,007 shares as a grant or award · Granted 10,013 Stock Option (Right to Buy)
08 Sep 2021	Form 4/A: Xencor Inc, 10% owner · INmune Bio Inc Acquired 192,533 shares (Other Transaction) ($3.3M)
08 Sep 2021	Form 4/A: Xencor Inc, 10% owner · INmune Bio Inc Acquired 192,533 shares (Other Transaction) ($3.3M)
03 Mar 2021	Form 4/A: Kuch John J, SR. VICE PRESIDENT & CFO Exercised 10,000 Stock Options
03 Mar 2021	Form 4/A: Kuch John J, SR. VICE PRESIDENT & CFO Exercised 20,000 Stock Options
03 Mar 2021	Form 4/A: Yang Allen, SR. VICE PRESIDENT & CMO Granted 62,300 Stock Options
03 Mar 2021	Form 4/A: Gustafson Kurt A, Director Granted 7,500 Stock Options
03 Mar 2021	Form 4/A: Montgomery Alan Bruce, Director Granted 7,500 Stock Options
03 Mar 2021	Form 4/A: Hata Yujiro S, Director Granted 7,500 Stock Options
05 Aug 2016	Form 4/A: Desjarlais John R, Sr. V.P., Research & CSO Sold 11,265 shares ($135K) · Received 6,888 shares by exercise or conversion ($4.06K) · Sold 2,635 shares ($31.6K)
24 Jun 2015	Form 4/A: Baracchini Edgardo Jr, Chief Business Officer Sold 1,277 shares ($25.3K)
13 Jun 2014	Form 4/A: Stafford John S Iii, Director Acquired 174,247 shares (Other Transaction)
22 Apr 2014	Form 4/A: Kuch John J, Vice President, Finance Received 2,500 shares by exercise or conversion ($1.48K)
22 Apr 2014	Form 4/A: Desjarlais John R, Vice President, Research Received 195 shares by exercise or conversion ($115)
13 Mar 2014	Form 4/A: Stafford John S Iii, Director Received 7,543,345 shares by conversion · Bought 275,000 shares ($1.51M)

Comments